Literature DB >> 25213006

Copeptin and arginine vasopressin at high altitude: relationship to plasma osmolality and perceived exertion.

A J Mellor1, C J Boos, S Ball, A Burnett, S Pattman, M Redpath, D R Woods.   

Abstract

PURPOSE: A diuresis is a key part of acclimatisation to high altitude (HA). Arginine vasopressin (AVP) is a hormone involved in salt and water balance and may potentially have a role in the development of altitude illness. ProAVP (copeptin) is more stable than AVP and is assayed by a straightforward, automated method. We investigated the relationship of AVP to copeptin and the copeptin response to exercise and altitude illness in a large cohort during a field study at HA.
METHODS: 48 subjects took part in a 10-day trek at HA. Venous blood samples were taken at 3,833, 4,450 and 5,129 m post-trek (exercise) and the following day at rest. Daily recordings of symptoms of altitude illness, oxygen saturations and perceived exertion were carried out.
RESULTS: AVP and copeptin levels increased with exercise and correlated closely (ρ 0.621 p < 0.001), this was strongest in the stressed state when AVP secretion was highest, at 5,129 m post-exercise (ρ 0.834 p < 0.001). On two-way ANOVA, both altitude (F = 3.5; p = 0.015) and exercise (F = 10.2; p = 0.002) influenced copeptin levels (interaction F = 2.2; p = 0.08). AVP levels were influenced by exercise (F = 14.4; p = 0.0002) but not altitude (F = 2.0; p = 0.12) with no overall group interactions (F = 1.92.6; p = 0.06). There was no association between copeptin or arginine vasopressin and altitude illness. Copeptin correlated with the Borg RPE score and was significantly higher in the group with a Borg score ≥15 (7.9 vs. 3.7 p < 0.001).
CONCLUSION: We have shown that arginine vasopressin and copeptin levels correlate and are suppressed below 5,129 m. Furthermore, we have demonstrated that exertion, rather than altitude illness or increasing osmolality, is the stimulus for increases in copeptin.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25213006     DOI: 10.1007/s00421-014-2994-7

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  27 in total

1.  Resistance to vasopressin action on the kidney in patients with Cushing's disease.

Authors:  M Knoepfelmacher; M J Pradal; R D Dio; L R Salgado; M Semer; B L Wajchenberg; B Liberman
Journal:  Eur J Endocrinol       Date:  1997-08       Impact factor: 6.664

2.  Copeptin and arginine vasopressin concentrations in critically ill patients.

Authors:  Stefan Jochberger; Nils G Morgenthaler; Viktoria D Mayr; Günter Luckner; Volker Wenzel; Hanno Ulmer; Siegfried Schwarz; Walter R Hasibeder; Barbara E Friesenecker; Martin W Dünser
Journal:  J Clin Endocrinol Metab       Date:  2006-08-29       Impact factor: 5.958

3.  Correlation of plasma copeptin and vasopressin concentrations in hypo-, iso-, and hyperosmolar States.

Authors:  Sandrina Balanescu; Peter Kopp; Mary Beth Gaskill; Nils G Morgenthaler; Christian Schindler; Jonas Rutishauser
Journal:  J Clin Endocrinol Metab       Date:  2011-02-02       Impact factor: 5.958

4.  European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

Authors:  Ian Graham; Dan Atar; Knut Borch-Johnsen; Gudrun Boysen; Gunilla Burell; Renata Cifkova; Jean Dallongeville; Guy De Backer; Shah Ebrahim; Bjørn Gjelsvik; Christoph Herrmann-Lingen; Arno Hoes; Steve Humphries; Mike Knapton; Joep Perk; Silvia G Priori; Kalevi Pyorala; Zeljko Reiner; Luis Ruilope; Susana Sans-Menendez; Wilma Scholte Op Reimer; Peter Weissberg; David Wood; John Yarnell; Jose Luis Zamorano; Edmond Walma; Tony Fitzgerald; Marie Therese Cooney; Alexandra Dudina; Alec Vahanian; John Camm; Raffaele De Caterina; Veronica Dean; Kenneth Dickstein; Christian Funck-Brentano; Gerasimos Filippatos; Irene Hellemans; Steen Dalby Kristensen; Keith McGregor; Udo Sechtem; Sigmund Silber; Michal Tendera; Petr Widimsky; Jóse Luis Zamorano; Attila Altiner; Enzo Bonora; Paul N Durrington; Robert Fagard; Simona Giampaoli; Harry Hemingway; Jan Hakansson; Sverre Erik Kjeldsen; mogens Lytken Larsen; Giuseppe Mancia; Athanasios J Manolis; Kristina Orth-Gomer; Terje Pedersen; Mike Rayner; Lars Ryden; Mario Sammut; Neil Schneiderman; Anton F Stalenhoef; Lale Tokgözoglu; Olov Wiklund; Antonis Zampelas
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2007-09

5.  Enhanced exercise-induced rise of aldosterone and vasopressin preceding mountain sickness.

Authors:  P Bärtsch; M Maggiorini; W Schobersberger; S Shaw; W Rascher; J Girard; P Weidmann; O Oelz
Journal:  J Appl Physiol (1985)       Date:  1991-07

6.  Sodium regulating hormones at high altitude: basal and post-exercise levels.

Authors:  M Zaccaria; S Rocco; D Noventa; M Varnier; G Opocher
Journal:  J Clin Endocrinol Metab       Date:  1998-02       Impact factor: 5.958

7.  Perceived exertion as an indicator of somatic stress.

Authors:  G Borg
Journal:  Scand J Rehabil Med       Date:  1970

8.  Response of plasma arginine vasopressin levels to rapid changes in altitude.

Authors:  M Porchet; H Contat; B Waeber; J Nussberger; H R Brunner
Journal:  Clin Physiol       Date:  1984-10

9.  Plasma adrenocorticotrophin and cortisol responses to acute hypoxia at rest and during exercise.

Authors:  P Bouissou; J Fiet; C Y Guezennec; P C Pesquies
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1988

10.  Gender and renal function influence plasma levels of copeptin in healthy individuals.

Authors:  Sanjay S Bhandari; Ian Loke; Joan E Davies; Ian B Squire; Joachim Struck; Leong L Ng
Journal:  Clin Sci (Lond)       Date:  2009-02       Impact factor: 6.124

View more
  5 in total

1.  Serum NGAL and copeptin levels as predictors of acute kidney injury in asphyxiated neonates.

Authors:  Małgorzata Baumert; Piotr Surmiak; Andrzej Więcek; Zofia Walencka
Journal:  Clin Exp Nephrol       Date:  2016-09-02       Impact factor: 2.801

Review 2.  Wilderness medicine at high altitude: recent developments in the field.

Authors:  Neeraj M Shah; Sidra Hussain; Mark Cooke; John P O'Hara; Adrian Mellor
Journal:  Open Access J Sports Med       Date:  2015-09-24

3.  Copeptin reflects physiological strain during thermal stress.

Authors:  Michael John Stacey; Simon K Delves; Sophie E Britland; Adrian J Allsopp; Stephen J Brett; Joanne L Fallowfield; David R Woods
Journal:  Eur J Appl Physiol       Date:  2017-10-27       Impact factor: 3.078

4.  Effect of Chronic Kidney Disease on Changes in Vasopressin System Expression in the Kidney Cortex in Rats with Nephrectomy.

Authors:  Katarzyna Czarzasta; Agnieszka Cudnoch-Jedrzejewska; Longin Niemczyk; Robert Wrzesien; Marzanna Tkaczyk; Liana Puchalska; Marek Saracyn; Wawrzyniec Zmudzki; Stanisław Niemczyk
Journal:  Biomed Res Int       Date:  2018-06-14       Impact factor: 3.411

5.  Heat acclimatization blunts copeptin responses to hypertonicity from dehydrating exercise in humans.

Authors:  Michael J Stacey; David R Woods; Stephen J Brett; Sophie E Britland; Joanne L Fallowfield; Adrian J Allsopp; Simon K Delves
Journal:  Physiol Rep       Date:  2018-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.